Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03070327
What this trial is testing

BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 20
Post-approval studies (Phase 4)UnknownNCT04989140
What this trial is testing

Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide

Who this might be right for
Multiple Myeloma
Peking Union Medical College Hospital 60
Early research (Phase 1)Study completedNCT01344876
What this trial is testing

Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaAcute Myeloid Leukemia+2 more
Otsuka Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Looking for participantsNCT07409246
What this trial is testing

Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
AbbVie 127
Large-scale testing (Phase 3)Looking for participantsNCT07649525
What this trial is testing

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

Who this might be right for
Multiple Myeloma (MM)Plasma Cell Leukemia (PCL)
University of Leeds 1,226
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07828522
What this trial is testing

F182112 in Combination With Isatuximab and Lenalidomide for the Treatment of Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Transplant-eligible Patients
Institute of Hematology & Blood Diseases Hospital, China 10
Testing effectiveness (Phase 2)Looking for participantsNCT05272826
What this trial is testing

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

Who this might be right for
Multiple Myeloma
Canadian Myeloma Research Group 75
Early research (Phase 1)Study completedNCT01497093
What this trial is testing

Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 34
Testing effectiveness (Phase 2)WithdrawnNCT01571726
What this trial is testing

Imaging Studies and the Development of Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT03465540
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaNon-Hodgkins Lymphoma+4 more
Amgen 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04094961
What this trial is testing

Ixazomib + Pomalidomide + Dexamethasone In MM

Who this might be right for
Multiple MyelomaMultiple Myeloma in Relapse
Omar Nadeem, MD 52
Not applicableNot Yet RecruitingNCT07353554
What this trial is testing

Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Peking Union Medical College Hospital 30
Not applicableStudy completedNCT01472627
What this trial is testing

Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 11
Not applicableUnknownNCT05735704
What this trial is testing

Early Detection and Screening of Hematological Malignancies - SANGUINE

Who this might be right for
Hematologic Malignancy
JaxBio Ltd 3,000
Early research (Phase 1)Study completedNCT00525447
What this trial is testing

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Seagen Inc. 36
Testing effectiveness (Phase 2)Ended earlyNCT01875237
What this trial is testing

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Who this might be right for
LeukemiaMyelomaMyeloproliferative Diseases
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT05928156
What this trial is testing

Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCT

Who this might be right for
Multiple MyelomaChronic Lymphocytic Leukemia
Duke University 77
Very early researchUnknownNCT04626752
What this trial is testing

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Hebei Senlang Biotechnology Inc., Ltd. 50
Testing effectiveness (Phase 2)UnknownNCT05509530
What this trial is testing

Safety and Efficacy of Anti-BCMA/GPRC5D CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma(rr/MM)

Who this might be right for
Multiple Myeloma
Xuzhou Medical University 30
Testing effectiveness (Phase 2)Ended earlyNCT04150965
What this trial is testing

Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT

Who this might be right for
Multiple MyelomaRelapsed Refractory Multiple Myeloma
Multiple Myeloma Research Consortium 14
Next Page